These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31093305)
1. KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells. Shen T; Yang L; Zhang Z; Yu J; Dai L; Gao M; Shang Z; Niu Y Dis Markers; 2019; 2019():4863182. PubMed ID: 31093305 [TBL] [Abstract][Full Text] [Related]
2. KIF20A Predicts Poor Survival of Patients and Promotes Colorectal Cancer Tumor Progression through the JAK/STAT3 Signaling Pathway. Zhang Q; Di J; Ji Z; Mi A; Li Q; Du X; Wang A; Wang A; Qin C Dis Markers; 2020; 2020():2032679. PubMed ID: 32695240 [TBL] [Abstract][Full Text] [Related]
3. Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer. Zhang Z; Chai C; Shen T; Li X; Ji J; Li C; Shang Z; Niu Y Dis Markers; 2019; 2019():4782730. PubMed ID: 31565099 [TBL] [Abstract][Full Text] [Related]
5. KIF20A as a potential biomarker of renal and bladder cancers based on bioinformatics and experimental verification. Wang H; Ma X; Li S; Su J; Fan B; Liu B; Ni X Aging (Albany NY); 2023 May; 15(11):4714-4733. PubMed ID: 37310408 [TBL] [Abstract][Full Text] [Related]
6. Kinesin family member 3A stimulates cell proliferation, migration, and invasion of bladder cancer cells in vitro and in vivo. Zhou Q; Yu J; Zheng Q; Wu T; Ji Z; Zhuo Y FEBS Open Bio; 2021 May; 11(5):1487-1496. PubMed ID: 31774623 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients. Liu SL; Lin HX; Qiu F; Zhang WJ; Niu CH; Wen W; Sun XQ; Ye LP; Wu XQ; Lin CY; Song LB; Guo L PLoS One; 2017; 12(1):e0169280. PubMed ID: 28081138 [TBL] [Abstract][Full Text] [Related]
8. Role of a Kinesin Motor in Cancer Cell Mechanics. Mandal K; Pogoda K; Nandi S; Mathieu S; Kasri A; Klein E; Radvanyi F; Goud B; Janmey PA; Manneville JB Nano Lett; 2019 Nov; 19(11):7691-7702. PubMed ID: 31565944 [TBL] [Abstract][Full Text] [Related]
9. SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors. Yin H; Qin C; Zhao Y; Du Y; Sheng Z; Wang Q; Song Q; Chen L; Liu C; Xu T Clin Transl Oncol; 2017 Aug; 19(8):1035-1044. PubMed ID: 28258492 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of kinesin family member 4A inhibits cell proliferation, migration, and invasion while promoting apoptosis of urothelial bladder carcinoma cells. Zhang C; Wang M; Ying Y; Meng F; Gao H; Zeng S; Zhu Y; Liu A; Zhang Z; Xu C Cancer Med; 2023 Jun; 12(11):12581-12592. PubMed ID: 37039264 [TBL] [Abstract][Full Text] [Related]
11. Low expression of KIF20A suppresses cell proliferation, promotes chemosensitivity and is associated with better prognosis in HCC. Wu C; Qi X; Qiu Z; Deng G; Zhong L Aging (Albany NY); 2021 Sep; 13(18):22148-22163. PubMed ID: 34491228 [TBL] [Abstract][Full Text] [Related]
12. Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade. Asai A; Miyata Y; Takehara K; Kanda S; Watanabe SI; Greer PA; Sakai H J Cancer Res Clin Oncol; 2018 Jan; 144(1):21-31. PubMed ID: 28952025 [TBL] [Abstract][Full Text] [Related]
13. High expression of KIF20A in bladder cancer as a potential prognostic target for poor survival of renal cell carcinoma. Liu B; Su J; Fan B; Ni X; Jin T Medicine (Baltimore); 2023 Jan; 102(2):e32667. PubMed ID: 36637953 [TBL] [Abstract][Full Text] [Related]
14. KIF22 promotes bladder cancer progression by activating the expression of CDCA3. Li K; Li S; Tang S; Zhang M; Ma Z; Wang Q; Chen F Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34633053 [TBL] [Abstract][Full Text] [Related]
15. Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer. Nakamura M; Takano A; Thang PM; Tsevegjav B; Zhu M; Yokose T; Yamashita T; Miyagi Y; Daigo Y Int J Oncol; 2020 Jul; 57(1):277-288. PubMed ID: 32467984 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis. Zhao X; Zhou LL; Li X; Ni J; Chen P; Ma R; Wu J; Feng J Cancer Med; 2018 Sep; 7(9):4678-4689. PubMed ID: 30105795 [TBL] [Abstract][Full Text] [Related]
17. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway. Wang FH; Ma XJ; Xu D; Luo J Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818 [TBL] [Abstract][Full Text] [Related]
18. CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer. Zhang XG; Zhang T; Li CY; Zhang MH; Chen FM Cancer Med; 2018 Aug; 7(8):3763-3772. PubMed ID: 30022623 [TBL] [Abstract][Full Text] [Related]
19. C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients. Zhu X; Tong H; Gao S; Yin H; Zhu G; Li X; He W; Gou X Biomed Res Int; 2020; 2020():7139721. PubMed ID: 33123583 [TBL] [Abstract][Full Text] [Related]
20. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma. Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]